Lv5
920 积分 2021-03-29 加入
Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer
5天前
已关闭
Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
6天前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
14天前
已完结
Dual Checkpoint Inhibition in Pancreatic Cancer
16天前
已完结
Tislelizumab: First Approval
21天前
已完结
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
22天前
已完结
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
27天前
已完结
Dostarlimab: Review on success story and clinical trials
28天前
已完结
皖公网安备34019202002308
